Interacting Drugs |
Colchicine vs CYP3A4 Inhibitors (Moderate) |
Security Level |
 |
Mechanism |
CYP3A4 Inhibitors (Moderate): May increase the serum concentration of Colchicine. |
Management |
Reduce colchicine dose as directed when using with a moderate CYP3A4 inhibitor, and increase monitoring for colchicine-related toxicity. Use extra caution in patients with impaired renal and/or hepatic function. |
Colchicine vs CYP3A4 Inhibitors (Moderate)
Post Review about Colchicine vs CYP3A4 Inhibitors (Moderate) Click here to cancel reply.
Other Interactions of Colchicine
Other Interactions of CYP3A4 Inhibitors (Moderate)
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.